Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02492997 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference
A NA study, sponsored by Venus Concept.
- Terminated
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02492997: Clinical Trial NA study, sponsored by Venus Concept.
NCT02492997 is a NA study that was terminated before completion, run by Venus Concept. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02492997, a NA study, was terminated before completion, sponsored by Venus Concept.
- TERMINATED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The octipolar applicator is intended for circumference reduction treatment by reduction of adipose size and enhancement of collagen synthesis as the result thermal and non-thermal collagen stimulation. This trial is intended to evaluate the effect of radio frequency (RF) and pulsed electromagnetic fields (PEMF) treatment on circumference reduction.
Primary Outcome
Abdominal circumference measurement of the treated area at 1 month after the last treatment performed by controlled tape measurement
Interventions
- DEVICE Venus Versa
- OTHER Glycerine gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-05-14 |
| Est. Completion | 2016-10-31 |
| Phase | NA |
Why NCT02492997 stopped before completion
NCT02492997 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Venus Versa is the first listed.
NCT02492997 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02492997 about?
NCT02492997 is a clinical study titled "Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference". The octipolar applicator is intended for circumference reduction treatment by reduction of adipose size and enhancement of collagen synthesis as the result thermal and non-thermal collagen stimulation. This trial is intended to evaluate the effect of radio frequency (RF) and pulsed electromagnetic f...
What is the current status of trial NCT02492997?
This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2015-05-14. Estimated completion is 2016-10-31.
What interventions are being tested in trial NCT02492997?
The interventions under investigation include: Venus Versa (DEVICE), Glycerine gel (OTHER).
Who is sponsoring clinical trial NCT02492997?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02492997's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI